Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks. 

Thumbnail

Deep learning reconstruction cuts prostate MRI acquisition time

And the shorter scan time does not come at the expense of image quality.

AI model spots missed breast cancers on MRI

AI model spots up to 30% of breast cancers missed on MRI

Re-evaluation by the second look algorithm could result in a cancer diagnosis up to one year earlier, especially for high risk disease.

breast cancer screening mammography

Radiology AI vendor Volpara Health inks $7M Department of Defense contract

The feds will deploy solutions for advanced mammography reporting, cancer risk assessment and patient tracking across the military health system. 

artificial intelligence AI in healthcare

Industry Watcher’s Digest

Michelle Tarver, MD, PhD, has her work cut out for her. 

artificial intelligence AI in healthcare

4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

HeartLung Technologies, a Houston-based artificial intelligence (AI) company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software that assesses chest CT scans for signs of coronary artery disease (CAD) and other potentially fatal heart conditions. The newly cleared offering, AutoChamber, was designed with opportunistic heart evaluations in mind.

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

artificial intelligence AI in healthcare

Industry Watcher’s Digest

Many if not most of today’s software developers use AI coding tools every day. Yet nearly 40% have little to no trust in AI-generated code.